This trial will compare how well miricorilant works in people with different degrees of liver impairment.
3 Primary · 5 Secondary · Reporting Duration: Pre-dose and 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 12, 24, 48, 72, 96, 120, and 144 hours post-dose
Experimental Treatment
36 Total Participants · 3 Treatment Groups
Primary Treatment: No Hepatic Impairment · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 75 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: